WG
AYTU icon

Winton Group’s AYTU BioPharma AYTU Stock Holding History

Winton Group’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,873
Closed -$165K – 1034
2021
Q3 		$165K Buy
2,873
+12
+0.4% +$901 0.01% 1259
2021
Q2 		$287K Buy
2,861
+529
+23% +$62.1K 0.02% 1200
2021
Q1 		$355K Buy
2,332
+899
+63% +$143K 0.02% 1064
2020
Q4 		$171K Buy
+1,433
New +$261K 0.01% 1212

Other funds holding AYTU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PSC
Piper Sandler & Co Minneapolis, Minnesota $135M AUM 0.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Winton Group's AYTU Position: Q4 2021 in Review

Winton Group sold out of AYTU BioPharma (AYTU) in Q4 2021, closing a stake of 2,873 shares — an estimated $165K sold.

Winton Group first reported a position in AYTU in Q4 2020 and held it in 4 quarters. The position peaked at $355K in Q1 2021. 37 funds tracked by Wall St. Rank hold AYTU as of Q4 2021.

  • Winton Group reported no remaining AYTU BioPharma position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 2,873 AYTU BioPharma shares in Q4 2021, an estimated $165K.
  • Winton Group first reported a position in AYTU BioPharma in Q4 2020 and held it in 4 quarters.
  • Winton Group's AYTU BioPharma position peaked at $355K in Q1 2021.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.